Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)

NCT01969708 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

362

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Retinal Vein Occlusion

Interventions

DRUG: aflibercept
DRUG: bevacizumab

Sponsor

The Emmes Company, LLC

Collaborators

[object Object]
[object Object]
[object Object]